ONCY Launches Phase 2 Colorectal Cancer Study, Pelareorep Granted Fast Track Designation in 2L KRAS-mutant MSS Metastatic Colorectal Cancer
Oncolytics Biotech, Inc. Common Shares · PHARMACEUTICAL PREPARATIONS · Now $1.06
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS